Natera (NTRA) Net Income towards Common Stockholders (2014 - 2026)
Natera's (NTRA) quarterly Net Income towards Common Stockholders came in at -$85.1 million in Q1 2026, down 27.15% YoY from -$116.8 million in Q1 2025, and down 280.09% on a QoQ basis from $47.3 million in Q4 2025.
Natera (NTRA) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends
Natera (NTRA) has 13 years of Net Income towards Common Stockholders data on file, last reported at -$85.1 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 27.15% year-over-year to -$85.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$226.4 million (down 19.28% YoY) and the FY2025 annual result came in at -$208.2 million, down 9.31% from the prior year.
- Net Income towards Common Stockholders slipped to -$85.1 million in Q1 2026, from $47.3 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $47.3 million in Q4 2025 to a low of -$145.2 million in Q2 2022.
- A 5-year average of -$86.3 million and a median of -$87.5 million in 2025 frame the typical range for Net Income towards Common Stockholders.
- The widest YoY moves for Net Income towards Common Stockholders: up 187.88% in 2025, down 177.11% in 2025.
- Tracing NTRA's Net Income towards Common Stockholders over 5 years: stood at -$142.6 million in 2022, then soared by 45.25% to -$78.1 million in 2023, then jumped by 31.11% to -$53.8 million in 2024, then surged by 187.88% to $47.3 million in 2025, then plunged by 280.09% to -$85.1 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$85.1 million (Q1 2026), $47.3 million (Q4 2025), and -$87.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 324.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -66.93 Mn |
| Mar 31, 2026 | -85.11 Mn |
| Dec 31, 2025 | 47.30 Mn |
| Sep 30, 2025 | -87.54 Mn |
| Jun 30, 2025 | -100.96 Mn |
| Mar 31, 2025 | -66.96 Mn |
| Dec 31, 2024 | -13.18 Mn |
| Sep 30, 2024 | -31.59 Mn |
| Jun 30, 2024 | -37.47 Mn |
| Mar 31, 2024 | -67.60 Mn |
| Dec 31, 2023 | 13.49 Mn |
| Sep 30, 2023 | -109.03 Mn |
| Jun 30, 2023 | -110.80 Mn |
| Mar 31, 2023 | -136.94 Mn |
| Dec 31, 2022 | -142.57 Mn |
| Sep 30, 2022 | -121.48 Mn |
| Jun 30, 2022 | -145.15 Mn |
| Mar 31, 2022 | -138.60 Mn |
| Dec 31, 2021 | -140.56 Mn |
| Sep 30, 2021 | -151.27 Mn |